Skip to main content
logo
Xenetic Biosciences, Inc. (XBIO)
NASDAQ: XBIO · Real-Time Price · USD
2.660
+0.125 (4.93%)
At close: Aug 3, 2026, 4:00 PM EDT
2.690
+0.030 (1.13%)
Pre-market: Aug 4, 2026, 7:05 AM EDT

Xenetic Biosciences Revenue

Xenetic Biosciences had revenue of $806.92K in the quarter ending March 31, 2026, with 36.01% growth. This brings the company's revenue in the last twelve months to $3.19M, up 23.52% year-over-year. In the year 2025, Xenetic Biosciences had annual revenue of $2.98M with 19.04% growth.

Revenue (ttm)
$3.19M
Revenue Growth
+23.52%
P/S Ratio
1.91
Revenue / Employee
$1,595,037
Employees
2
Market Cap
6.09M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20252.98M476.13K19.04%
Dec 31, 20242.50M-39.70K-1.56%
Dec 31, 20232.54M833.06K48.80%
Dec 31, 20221.71M546.23K47.06%
Dec 31, 20211.16M723.75K165.64%
Dec 31, 2020436.94K419.88K2,460.31%
Dec 31, 201917.07K--
Dec 31, 2018---
Dec 31, 20177.59M4.59M152.83%
Dec 31, 20163.00M--
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 20131.00M706.40K240.60%
Dec 31, 2012293.60K--
Aug 31, 2012---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

XBIO News

More News